Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype.

Loading...
Thumbnail Image

Date

1988-09

Authors

Regan, JW
Kobilka, TS
Yang-Feng, TL
Caron, MG
Lefkowitz, RJ
Kobilka, BK

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

280
views
359
downloads

Abstract

An alpha 2-adrenergic receptor subtype has been cloned from a human kidney cDNA library using the gene for the human platelet alpha 2-adrenergic receptor as a probe. The deduced amino acid sequence resembles the human platelet alpha 2-adrenergic receptor and is consistent with the structure of other members of the family of guanine nucleotide-binding protein-coupled receptors. The cDNA was expressed in a mammalian cell line (COS-7), and the alpha 2-adrenergic ligand [3H]rauwolscine was bound. Competition curve analysis with a variety of adrenergic ligands suggests that this cDNA clone represents the alpha 2B-adrenergic receptor. The gene for this receptor is on human chromosome 4, whereas the gene for the human platelet alpha 2-adrenergic receptor (alpha 2A) lies on chromosome 10. This ability to express the receptor in mammalian cells, free of other adrenergic receptor subtypes, should help in developing more selective alpha-adrenergic ligands.

Type

Journal article

Department

Description

Provenance

Subjects

Amino Acid Sequence, Animals, Base Sequence, Cell Line, Chromosomes, Human, Pair 4, Cloning, Molecular, DNA, Genes, Humans, Kidney, Kinetics, Models, Molecular, Molecular Sequence Data, Protein Conformation, Receptors, Adrenergic, alpha, Transcription, Genetic

Citation


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.